CINC Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Feb 2023 @ 16:00):

Stats
Today's Volume	0.00
Average Volume	625 748
Market Cap	1.27B
EPS	$0 ( 2023-03-28 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-14.46
ATR14	$0.860 (2.96%)

Insider Trading

Date	Person	Action	Amount	type
2023-02-24	5am Partners Vi, Llc	Sell	496 323	Common Stock
2023-02-24	Healy James	Sell	9 803	Common Stock
2022-11-28	Healy James	Sell	6 000	Common Stock
2023-02-24	Healy James	Sell	19 608	Common Stock
2023-02-24	Healy James	Sell	6 073 949	Common Stock

INSIDER POWER
-68.43
Last 98 transactions
Buy: 39 839 974 \| Sell: 98 795 779

Volume Correlation

Long: -0.03 (neutral)

Short: -0.86 (strong negative)

Signal:(69.258) Neutral

CinCor Pharma, Inc. Correlation

10 Most Positive Correlations
TCBX	0.88
ADV	0.878
SNCR	0.87
RDVT	0.869
PVBC	0.864
DWSH	0.863
ALTO	0.861
TSLA	0.854
GILT	0.85
SWIM	0.847

10 Most Negative Correlations
BYFC	-0.939
STTK	-0.935
CNTY	-0.925
MBIN	-0.914
SLMBP	-0.907
DOOO	-0.905
TREE	-0.905
CASH	-0.903
TTSH	-0.902
TBBK	-0.897

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CinCor Pharma, Inc. Correlation - Currency/Commodity

0.32
( neutral )

0.40
( neutral )

-0.69
( moderate negative )

0.61
( weak )

-0.14
( neutral )

-0.07
( neutral )

CinCor Pharma, Inc. Financials

Annual	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1 422.09

Q3	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.480

Q2	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.540

Q1	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.590

Financial Reports:

No articles found.

CinCor Pharma, Inc.

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.